ČESKÉ BUDĚJOVICE

DGAP-News: SBF AG increases revenues by around 50 % in the first half of 2021

Retrieved on: 
Thursday, August 19, 2021

According to preliminary figures for the first half of 2021, revenues increased significantly.

Key Points: 
  • According to preliminary figures for the first half of 2021, revenues increased significantly.
  • SBF generated consolidated revenues of EUR 15.2 million in the first half of the year (H1 2020: EUR 10.0 million).
  • The new business area contributed EUR 4.0 million to consolidated revenues in the first half of the year.
  • Rudolf Witt, Member of the Management Board of SBF AG comments: "The demand for modern, energy-saving LED lighting systems remains persistently high.

DGAP-News: Biotest AG: Biotest increases sales by 10% in the first half of 2021

Retrieved on: 
Thursday, August 12, 2021

In the first half of financial year 2021, the Biotest Group recorded a revenue in the amount of 257.8 million (same period of the previous year: 234.8 million).

Key Points: 
  • In the first half of financial year 2021, the Biotest Group recorded a revenue in the amount of 257.8 million (same period of the previous year: 234.8 million).
  • Furthermore, sales of other products, such as Haemoctin(R) and Albumin were also higher compared to the first half-year of 2020.
  • This includes expenses of 38.0 million for the Biotest Next Level project (same period of the previous year: 40.3 million).
  • The Biotest Group's total earnings after taxes (EAT) for the first half of 2021 amounted to -18.2 million (same period of the previous year: -16.7 million).

DGAP-News: Biotest AG: Biotest AG opens fifth plasma collection centre in Czech Republic

Retrieved on: 
Wednesday, June 30, 2021

Biotest has received the operating license for its fifth plasma collection centre in Czech Republic from the country's national public health authority SUKL.

Key Points: 
  • Biotest has received the operating license for its fifth plasma collection centre in Czech Republic from the country's national public health authority SUKL.
  • The centre is located in the historic centre of the South Bohemian city of Budweis.
  • Biotest is continuing on its planned path to expand its own donation stations in order to increase its plasma collection capacity.
  • The ordinary and preference shares of Biotest AG are listed in the Prime Standard on the German stock exchange.